FLUCELVAX (Seqirus Pty Ltd)
Product name
FLUCELVAX
Sponsor
Date registered
Evaluation commenced
Decision date
Approval time
180 (255 working days)
Active ingredients
Influenza virus haemagglutinin
Registration type
NCE/ NBE
Indication
For the prevention of influenza caused by Influenza Virus, Types A and B contained in the vaccine. The vaccine is indicated for use in adults and children 6 months of age and older.